Description

Pagamax (pregabalin) gelatin capsules 150 mg. №14

Ingredients

Each gelatin capsule contains 150 mg of pregabalin.

Dosage

The recommended dosage is as prescribed by a healthcare provider. It is typically taken orally with or without food.

Indications

Pagamax capsules are indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia.

Contraindications

Do not use Pagamax if you are allergic to pregabalin or any of the other ingredients in the capsules. It is also contraindicated in patients with heart problems.

Directions

Follow the instructions provided by your healthcare provider for the proper use of Pagamax. Do not exceed the recommended dosage.

Scientific Evidence

Studies have shown that pregabalin is effective in reducing neuropathic pain and improving quality of life in patients with various chronic pain conditions. Research published in the Journal of Pain Research demonstrated the efficacy of pregabalin in the management of neuropathic pain.

Additional Information

It is important to discuss any existing medical conditions and medications with your healthcare provider before starting Pagamax. Common side effects may include dizziness, drowsiness, and weight gain.

Pregabalin, the active ingredient in Pagamax, exerts its pharmacological effects by binding to calcium channels in the central nervous system, modulating the release of neurotransmitters involved in pain signaling. This mechanism helps to reduce abnormal electrical activity in the brain, thereby alleviating neuropathic pain.

In comparative effectiveness studies, pregabalin has shown similar or superior efficacy compared to other medications commonly used for neuropathic pain. A meta-analysis published in the Journal of Clinical Pharmacy and Therapeutics concluded that pregabalin is a valuable treatment option for neuropathic pain with a favorable safety profile.